Showing results (51-60 of 56) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 26, 2018
Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitisMohammad Javad Fattahi, Hossein Ahmadi, Fahimeh Jafarnezhad-Ansariha, et al.Immunopharmacology and Immunotoxicology|November 20, 2015
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drugMohammad Javad Fattahi, Mohammad Abdollahi, Asghar Agha Mohammadi, et al.The Indian Journal of Medical Research|November 13, 2023
Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000)Mohammad Javad Fattahi, Bernd H A Rehm, Hidenori Matsuo, et al.Inflammopharmacology|August 19, 2017
The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell lineFahimeh Jafarnezhad-Ansariha, Mir Saeed Yekaninejad, Ahmad-Reza Jamshidi, et al.International Immunopharmacology|November 12, 2017
Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trialMohammad Javad Fattahi, Ahmad Reza Jamshidi, Mahdi Mahmoudi, et al.Inflammopharmacology|April 27, 2018
A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-D-mannuronic acid in rheumatoid arthritis patientsHossein Ahmadi, Ahmad Reza Jamshidi, Farhad Gharibdoost, et al.Pageof 6